The Discounted Cash Flow (DCF) valuation of Amicus Therapeutics Inc (FOLD) is 0.46 USD. With the latest stock price at 14.21 USD, the upside of Amicus Therapeutics Inc based on DCF is -96.8%.
Based on the latest price of 14.21 USD and our DCF valuation, Amicus Therapeutics Inc (FOLD) is a sell. selling FOLD stocks now will result in a potential gain of 96.8%.
| Range | Selected | |
| WACC / Discount Rate | 6.5% - 9.5% | 8.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (0.09) - 2.79 | 0.46 |
| Upside | -100.6% - -80.4% | -96.8% |